Spanish Red Biotech Pipeline

SECUGEN

GENOTYPING

Type: Diagnostic/Imaging
Therapeutic area: Ophthalmology and optometry
Indication: Genetic risk for Age related Macular Degeneration
Phase: 5Ready to Market, 4Register, 3Clinical validation, 2Preclinical Validation, 1R+D
Studies location: Worldwide